This article examines the cultural phenomenon of the 'peptide craze,' specifically focusing on the off-label use of GLP-1 receptor agonists like semaglutide and tirzepatide for weight loss and wellness. It discusses how the demand for these injectable diabetes drugs has shifted the public perception of risk, leading individuals to seek out unregulated sources. The piece highlights the disconnect between the medical necessity of these drugs and their casual use for cosmetic or lifestyle enhancement.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.